Studies have consistently shown significant weight reduction in participants using these medications, often surpassing traditional weight loss methods
Document mood symptoms, timing of medication doses, food intake, blood glucose readings, and other relevant factors
In addition, integration with existing cancer therapies, including surgery, radiotherapy, and targeted therapies remain unstudied
We believe that long-term weight loss is the result of a combination of healthy choices and not quick fixes
Literature has shown that GLP-1 agonists have a beneficial effect when changing impulsive behavior in AUD
BMI plays an important role in determining eligibility for GLP-1 weight loss treatments, as it helps assess the degree of obesity and associated health risks